More on ARVN

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-77.1% Growth)
- Ratings (6.0 Score)

Upcoming Events

- Earnings (11/10/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Arvinas Inc. (NQ:ARVN)
Delayed: 8.68 -0.08 (0.91%)
Prev. Close $8.76  
Open$8.67 
52 Wk High$ 
52 Wk Low$ 
Day High$8.78 
Day Low$8.47 
P/E N/A  
EPS$ 
Volume414,489 

Friends, Peers and Foes (?): PFE, DGX, EXAS, ILMN, QTRX (more...)

Sep 3, 2026 04:01 PM Arvinas to Participate in Upcoming Investor Conferences
Sep 1, 2026 04:01 PM Arvinas Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Sep 1, 2026 09:07 AM Piper Sandler on Biotechnology: 'Look for Biotech to Outperform through YE:26'
Aug 14, 2026 04:25 PM Form SCHEDULE 13G/A ARVINAS, INC. Filed by: D. E. SHAW & CO, L.P.
Aug 10, 2026 08:36 AM Arvinas Inc. (ARVN) PT Lowered to $10 at Morgan Stanley
Aug 4, 2026 04:13 PM Form 144 ARVINAS, INC. Filed by: Berkowitz Noah
Aug 4, 2026 04:10 PM Form 10-Q ARVINAS, INC. For: Jun 30
Aug 4, 2026 01:11 PM Wells Fargo Downgrades Arvinas Inc. (ARVN) to Equal Weight
Aug 4, 2026 01:08 PM BTIG Reiterates Buy Rating on Arvinas Inc. (ARVN)
Aug 4, 2026 07:28 AM Arvinas, Inc. (ARVN) Tops Q2 EPS by 296c
View All Articles

Entities mentioned with ARVN

View All Entities